Lv1
46 积分 2022-07-19 加入
Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial
2个月前
已完结
Therapeutic strategies for sarcopenic obesity: a systematic review
3个月前
已完结
Obesity as a multisystem disease: Trends in obesity rates and obesity‐related complications
3个月前
已完结
Overall Survival with Inavolisib in PIK3CA -Mutated Advanced Breast Cancer
3个月前
已完结
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
3个月前
已完结
The Phosphoinositide 3-Kinase Pathway
3个月前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
3个月前
已完结
Structural Insights into the Development of Inhibitors Against Cancer-Specific Mutations of PI3Kα
3个月前
已完结
[Guidelines on tests of PIK3CA mutation in breast cancer in China (2025 version)]
4个月前
已完结
The present and future of PI3K inhibitors for cancer therapy
4个月前
已完结
皖公网安备34019202002308
